Volume 4, Issue 6 742865 pp. 297-305
Open Access

Staging Lung Cancer: Current Controversies and Strategies

Riyad Karmy-Jones

Corresponding Author

Riyad Karmy-Jones

Division of Thoracic Surgery University of Washington Seattle, Washington, USA , washington.edu

Search for more papers by this author
Robert H Hyland

Robert H Hyland

Department of Medicine Wellesley Central Hospital Toronto, Ontario, Canada

Search for more papers by this author
Joseph W Lewis Jr

Joseph W Lewis Jr

Division of Thoracic Surgery University of Washington Seattle, Washington, USA , washington.edu

Search for more papers by this author
Paul Kvale

Paul Kvale

Divisions of Thoracic Surgery and Pulmonary Medicine Henry Ford Hospital Detroit, Michigan, USA , henryford.com

Search for more papers by this author
First published: 03 December 1997
Citations: 6

Abstract

A consistent approach to staging is required for the rational management of lung cancer. This paper was prepared at the request of the Standards Committee of the Canadian Thoracic Society, and reviews and discusses the relative merits of the available methods of staging. Whichever methods are chosen by a particular institution, the following points must be stressed. No patient can be considered automatically "unresectable" when chest radiography and/ or computed tomography demonstrate adenopathy or only suggest local invasion. Clinical and/or radiographical evidence suggesting extensive local or metastatic disease should be evaluated as completely as possible before subjecting the patient to a possible "nontherapeutic" thoracotomy. Finally, in some cases thoracotomy is required to decide whether the lesion is "completely" resectable.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.